Biosimilars – Keys to Success in the Medical Benefit
Monday, October 2, 2023
11:15 a.m. - 12:15 p.m.
Biosimilars are delivering on their promise of savings and increased patient access. And while some biosimilars have seen rapid market adoption, other biosimilars have not been as successful. This panel will discuss the state of the market for biosimilars covered under the medical benefit, reflect on differences in adoption to date, and highlight any key learnings for achieving commercial success in the future.
Principal, US Market Access Strategy, IQVIA Institute for Human Data Science
Mary Jo Carden, RPh, JD
Head, Policy, Corporate Affairs, Sandoz Pharmaceuticals
Shannon Holden, PharmD, BCACP, CACP
Sr. Clinical Manager, Pharmacy, Vizient, Inc.
Director, Policy, AAM